125 related articles for article (PubMed ID: 10071757)
1. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts.
Lutz RA; Feng N; Moser R
J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2.
Feng N; Lugli SM; Schnyder B; Gauchat JF; Graber P; Schlagenhauf E; Schnarr B; Wiederkehr-Adam M; Duschl A; Heim MH; Lutz RA; Moser R
Lab Invest; 1998 May; 78(5):591-602. PubMed ID: 9605184
[TBL] [Abstract][Full Text] [Related]
3. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
Kuznetsov VA; Puri RK
Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
[TBL] [Abstract][Full Text] [Related]
5. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor.
Gauchat JF; Schlagenhauf E; Feng NP; Moser R; Yamage M; Jeannin P; Alouani S; Elson G; Notarangelo LD; Wells T; Eugster HP; Bonnefoy JY
Eur J Immunol; 1997 Apr; 27(4):971-8. PubMed ID: 9130652
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of human IL-13 and implication for receptor binding.
Moy FJ; Diblasio E; Wilhelm J; Powers R
J Mol Biol; 2001 Jun; 310(1):219-30. PubMed ID: 11419948
[TBL] [Abstract][Full Text] [Related]
7. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.
Donaldson DD; Whitters MJ; Fitz LJ; Neben TY; Finnerty H; Henderson SL; O'Hara RM; Beier DR; Turner KJ; Wood CR; Collins M
J Immunol; 1998 Sep; 161(5):2317-24. PubMed ID: 9725226
[TBL] [Abstract][Full Text] [Related]
8. Characterization of interleukin-13 receptor in carcinoma cell lines and human blood cells and comparison with the interleukin-4 receptor.
Feng N; Schnyder B; Vonderschmitt DJ; Ryffel B; Lutz RA
J Recept Signal Transduct Res; 1995; 15(7-8):931-49. PubMed ID: 8673724
[TBL] [Abstract][Full Text] [Related]
9. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
10. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
Andrews AL; Holloway JW; Holgate ST; Davies DE
J Immunol; 2006 Jun; 176(12):7456-61. PubMed ID: 16751391
[TBL] [Abstract][Full Text] [Related]
11. Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease.
Mentink-Kane MM; Wynn TA
Immunol Rev; 2004 Dec; 202():191-202. PubMed ID: 15546394
[TBL] [Abstract][Full Text] [Related]
12. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
Kawakami K; Leland P; Puri RK
Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446
[TBL] [Abstract][Full Text] [Related]
13. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R.
Kioi M; Kawakami K; Puri RK
Cell Immunol; 2004 May; 229(1):41-51. PubMed ID: 15331327
[TBL] [Abstract][Full Text] [Related]
15. Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells.
Murata T; Obiri NI; Debinski W; Puri RK
Biochem Biophys Res Commun; 1997 Sep; 238(1):90-4. PubMed ID: 9299458
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of interleukin-13 and insights into receptor engagement.
Eisenmesser EZ; Horita DA; Altieri AS; Byrd RA
J Mol Biol; 2001 Jun; 310(1):231-41. PubMed ID: 11419949
[TBL] [Abstract][Full Text] [Related]
17. A soluble form of IL-13 receptor alpha 1 promotes IgG2a and IgG2b production by murine germinal center B cells.
Poudrier J; Graber P; Herren S; Gretener D; Elson G; Berney C; Gauchat JF; Kosco-Vilbois MH
J Immunol; 1999 Aug; 163(3):1153-61. PubMed ID: 10415009
[TBL] [Abstract][Full Text] [Related]
18. Differential responses of human monocytes and macrophages to IL-4 and IL-13.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Donnelly RP; Finlay-Jones JJ
J Leukoc Biol; 1999 Oct; 66(4):575-8. PubMed ID: 10534111
[TBL] [Abstract][Full Text] [Related]
19. Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells.
Chin J; Rupp E; Cameron PM; MacNaul KL; Lotke PA; Tocci MJ; Schmidt JA; Bayne EK
J Clin Invest; 1988 Aug; 82(2):420-6. PubMed ID: 2969918
[TBL] [Abstract][Full Text] [Related]
20. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
